Clindesse Cream
Product Images NDC 45802-042

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Clindesse (NDC 45802-042). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Israel Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2s0e6rcc3

Clindesse vaginal cream 2% (clindamycin phosphate) carton. This prescription human drug is supplied in a 5.8 g package and contains a convenient, prefilled, and disposable applicator delivering approximately 100 mg clindamycin in 5 g cream. Manufactured by Padagis Israel Pharmaceuticals Ltd and distributed by Perrigo.*

FDA Label Image

Aa398rcc3

Clindesse (clindamycin phosphate) Vaginal Cream, 2%, 5.8 g package carton. The label states the product is a prefilled, disposable applicator for one complete course of therapy. It is RX only and marked as a professional sample not to be sold. Manufactured by Perrigo in Israel and distributed by Perrigo. The NDC is 45802-042-02.*

FDA Label Image

Image 01

A data table comparing adverse events between Clindesse vaginal cream 100 mg/5g and placebo groups, each with 85 participants. The table lists events such as vaginosis fungal NOS, headache NOS, back pain, constipation, and urinary tract infection NOS, showing the number and percentage of cases in each group.*

FDA Label Image

Image 02

Chemical structure diagram of clindamycin phosphate, the active ingredient in Clindesse vaginal cream 100 mg/5g by Padagis Israel Pharmaceuticals Ltd, showing molecular bonds and functional groups.*

FDA Label Image

Image 03

Data table comparing cure rates for Clindesse cream versus placebo. It shows percentages of therapeutic cure, clinical cure, and Nugent score cure, along with treatment differences and their 95% confidence intervals between Clindesse and placebo groups.*

FDA Label Image

Image 04

A data table comparing outcomes of therapeutic cure, clinical cure, and Nugent score cure percentages between Clindesse single-dose 5 g vaginal cream and Clindamycin vaginal cream administered in seven doses. The table also presents the treatment differences in percentage with 95% confidence intervals for each outcome.*

FDA Label Image

Image 05

A data table comparing percentage cure outcomes for Clindesse single dose (N=126) and Clindamycin vaginal cream (7 doses, N=125). Outcomes include Therapeutic Cure, Clinical Cure, and Nugent Score Cure, alongside treatment differences with 95% confidence intervals.*

FDA Label Image

Image 06

Illustrations labeled Figure 1 and Figure 2 showing a vaginal applicator for drug administration. Key parts labeled include the Ring, Plunger, Applicator tube, and Tip, demonstrating the components and structure of the applicator device.*

FDA Label Image

Image 07

An instructional illustration showing hands holding and preparing a vaginal cream applicator, likely demonstrating proper usage or insertion technique. The figure is labeled as 'Figure 3.'*

FDA Label Image

Image 08

An instructional illustration showing hands and a vaginal applicator for cream administration. Figure 4 depicts hands manipulating the vaginal area, and Figure 5 shows insertion of the applicator into the vagina, demonstrating how to apply the cream vaginally.*

FDA Label Image

Serialization Template 01

Clindesse 100 mg/5g vaginal cream label imprint area showing placeholders for serial number (S/N), lot number, and expiration date (Exp). The label instructs to insert the product's unique serial number, lot number, and expiration date in designated spaces.*

FDA Label Image

Serialization Template

A rectangular label with placeholder text fields for serial number, lot number, and expiration date, intended for Clindesse (clindamycin phosphate) vaginal cream 100 mg/5g, supplied by Padagis Israel Pharmaceuticals Ltd.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.